HLB Group Establishes ESG Management Committee... Management Transparency '↑'

[Asia Economy Reporter Yoo Hyun-seok] HL Biopharma Group announced on the 19th that it will embark on full-scale ESG (Environmental, Social, and Governance) management by establishing an ESG Management Committee.

HL Biopharma Group had previously established a group ESG management team in April and declared the introduction of an ESG management system. As a follow-up measure, the group has now established a group ESG Management Committee composed of presidents of its listed affiliates, aiming to strengthen supervision to ensure that management activities in each business sector, including pharmaceuticals and bio, leisure, food and beverage, and beauty, are conducted in accordance with the group’s ESG management strategies and guidelines.

To this end, HL Biopharma Group’s four listed affiliates?HL Biopharma, HL Biopharma Life Science, HL Biopharma Pharmaceutical, and Next Science?have each established ESG committees composed of two outside directors (including the chairperson) and one inside director through their regular third-quarter board meetings. The newly established ESG committees of each company plan to systematically carry out specific projects tailored to the characteristics of each affiliate in accordance with the policies of the group ESG Management Committee.

Nam Sang-woo, Chairperson of the HL Biopharma Group ESG Management Committee, stated, “For HL Biopharma Group, which has long strived to realize the dream of better lives and life extension for humanity, ESG management that enhances the group’s sustainability through environmentally and socially friendly activities is a very natural and familiar trend. We will strengthen the functions of the ESG committee so that ESG management activities, including management transparency, ethical management, safety and health, and eco-friendly policies, can firmly establish themselves as part of the organizational culture across all aspects of management.”